GlobalData on MSN2mon
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases
Identifying anaphylaxis associated with glatiramer acetate can be challenging because its initial symptoms are similar to immediate post-injection reaction, a temporary and common side effect.
pharmaphorum3d
EU says Teva blocked generics to MS drug Copaxone
Teva's last remaining Copaxone (glatiramer acetate) patent expired in Europe in February 2015 and the Commission said last March it was investigating whether the company acted lawfully in trying ...